PEOPLE - Eclipse Surgical Technologies announces resignation:
This article was originally published in Clinica
US transmyocardial revascularisation company Eclipse Surgical Technologies has announced the resignation for personal reasons of its president and CEO, Allen Hill. Alan Kaganov, a director of the company, becomes interim CEO.
You may also be interested in...
Cilta-cel maintained high response rates in longer-term multiple myeloma data, but ide-cel causes less cytokine release syndrome and severe neurotoxicity – and it has a March decision date at the US FDA.
Our updated graphic tracker of key developments from the leading vaccine candidates.
Pathway open for drug as post-covalent BTK option as Loxo gears up for "risky" Phase III head-to-head study in Q1 2021.